Meihua Medical (MHUA) - Forward Price-to-Revenue Multiple

Meihua Medical Technologies (MHUA) - corporate logo

Stable demand for syringes provides MeihuaMed (MHUA) with a consistent cash flow, supporting the company's forward P/S. The latest value is recorded as 2.70, reflecting market expectations. Growth is sustained by large-scale distribution and a network of plants in the PRC, which eliminate shortages. The leader's strategy is based on the mass export of high-quality consumables while maintaining minimal production costs.

MHUA Meihua Medical Technologies Co., Ltd.: Forward Price-to-Revenue Multiple in the range 04/28/2023 - 12/13/2025

Meihua Medical - analytical breakdowns and key metrics (MHUA)

- market price and analyst price targets:
Price Chart MeihuaMed|MHUA - Fair Value Consensus
- market capitalization indicators:
Market Valuation MeihuaMed|MHUA - Enterprise Value
- business book valuation details:
Net Assets per Single Share MeihuaMed|MHUA - Company Net Assets|Market Capitalization to Book Value Ratio meihuamed.com|MHUA - Company Assets
- issuer credit burden and liquidity indicators:
Debt to Equity MeihuaMed|MHUA - Long-Term Debt to Capital Ratio|Short-Term Debt to Equity Ratio Meihua Medical Technologies Co., Ltd.|MHUA - Company Cumulative Indebtedness|Debt to Book Capitalization Ratio Meihua Medical|MHUA - Long-Term Debt Volume|Company Short-Term Debt MeihuaMed|Quick Ratio meihuamed.com
- business earnings and investment ratios data:
MHUA - Company Net Income|Projected Future Earnings MeihuaMed|MHUA - Business Payback Period|Forward P/E Multiple MeihuaMed|MHUA - Growth-Adjusted Payback Ratio|Enterprise Value to EBITDA Ratio MeihuaMed|MHUA - Operating profit EBITDA|Net earnings per share (EPS TTM) MeihuaMed|MHUA - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months meihuamed.com|MHUA - Net earnings per share growth this year|Earnings growth forecast for next year MeihuaMed
- sales and revenue data:
MHUA - Company Total Revenue|Projected Sales Volume meihuamed.com|MHUA - Market Cap to Revenue Ratio|Price-to-Projected Revenue Ratio Meihua Medical Technologies
General company analysis:MHUA (Meihua Medical Technologies)
Original product of Meihua Medical Technologies

Finding a balance between cost and business quality requires an analysis of the forward P/S, which determines the price per unit of projected revenue and reveals overvaluation risks amid low asset liquidity. For MeihuaMed (MHUA), the expected P/S ratio reflects market expectations for the commercialization of medical innovations, where stable product demand smooths out cyclicality but leaves the chart's dynamics dependent on the success of clinical trials.

Analysis of competing companies

Price-to-Projected Revenue Ratio Intuitive Surgical Inc ISRG|Forward P/S Multiple Danaher Corporation Inc. DHR|BDX - Price-to-Projected Revenue Ratio|STERIS plc (STE) - Forward Price-to-Revenue Multiple|WST: Forward P/S Multiple|Market Cap to Future Revenue Ratio Baxter International Inc. (BAX)|MASI (masimo.com) - Forward P/S Multiple|Market Cap to Future Revenue Ratio Stevanato Group Corp STVN|Forward Price-to-Revenue Multiple TFX (Teleflex Inc)|Merit Medical - Market Cap to Projected Revenue|Envista Holdings - Forward Price-to-Revenue Multiple|Price to Expected Revenue Ratio ICUI (ICU Medical Inc)|XRAY - Price-to-Projected Revenue Ratio|Market Cap to Expected Sales Ratio LeMaitre Corp LMAT|ATRC: Forward P/S Multiple|STAA - Market Cap to Expected Sales Ratio|NAGE (Chromadex Corp) - Forward P/S Multiple|ZimVie Inc (ZIMV) - Market Cap to Expected Sales Ratio|Forward P/S Multiple ANGO|CERS (Cerus Corporation) - Forward Price to Sales|Forward P/S Multiple TKNO (Alpha Teknova, Inc.)|Monogram Technologies (MGRM) - Market Cap to Future Revenue Ratio|STSS - Price-to-Projected Revenue Ratio|Market Cap to Expected Sales Ratio InfuSystem INFU|Utah Med (UTMD) - Price-to-Projected Revenue Ratio|Forward Price-to-Revenue Multiple KORU Medical Systems, Inc.|Forward Price-to-Revenue Multiple NYXH|Market Cap to Future Revenue Ratio Microbot Medical MBOT|Forward Price-to-Revenue Multiple PDEX (Pro-Dex)|Price-to-Projected Revenue Ratio ZTEK (Zentek Limited)|Price-to-Projected Revenue Ratio Elutia Inc. ELUT|Milestone Scientific (MLSS) - Market Cap to Future Revenue Ratio|nexgel.com - Forward P/S Multiple|Market Cap to Future Revenue Ratio Retractable Technologies Inc.|Harvard Bioscience Inc. (HBIO) - Price-to-Projected Revenue Ratio|Forward Price-to-Revenue Multiple Femasys Corp|Price-to-Projected Revenue Ratio Predictive Oncology Inc|callanjmb.com (CJMB) - Market Cap to Expected Sales Ratio|Price-to-Projected Revenue Ratio Atrion Corporation (ATRI)|Market Cap to Expected Sales Ratio neurometrix.com